121 related articles for article (PubMed ID: 2407368)
1. Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study.
Vlasveld LT; Beynen JH; Boogerd W; Ten Bokkel Huinink WW; Rodenhuis S
Cancer Chemother Pharmacol; 1990; 25(5):382-3. PubMed ID: 2407368
[TBL] [Abstract][Full Text] [Related]
2. Complete remission of brain metastases from ovarian carcinoma with carboplatin.
Cormio G; Gabriele A; Maneo A; Zanetta G; Bonazzi C; Landoni F
Eur J Obstet Gynecol Reprod Biol; 1998 May; 78(1):91-3. PubMed ID: 9605456
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin.
Cooper KG; Kitchener HC; Parkin DE
Gynecol Oncol; 1994 Nov; 55(2):318-23. PubMed ID: 7959302
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
Kastritis E; Efstathiou E; Gika D; Bozas G; Koutsoukou V; Papadimitriou C; Pissakas G; Dimopoulos MA; Bamias A
Int J Gynecol Cancer; 2006; 16(3):994-9. PubMed ID: 16803475
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian Carcinoma.
Piccart MJ; Nogaret JM; Marcelis L; Longrée H; Ries F; Kains JP; Gobert P; Domange AM; Sculier JP; Gompel C
J Natl Cancer Inst; 1990 Apr; 82(8):703-7. PubMed ID: 2181152
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin.
Mangioni C; Bolis G; Pecorelli S; Bragman K; Epis A; Favalli G; Gambino A; Landoni F; Presti M; Torri W
J Natl Cancer Inst; 1989 Oct; 81(19):1464-71. PubMed ID: 2674459
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.
Speyer JL; Beller U; Colombo N; Sorich J; Wernz JC; Hochster H; Green M; Porges R; Muggia FM; Canetta R
J Clin Oncol; 1990 Aug; 8(8):1335-41. PubMed ID: 2199620
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin/cyclophosphamide combination chemotherapy for advanced ovarian cancer.
Teeling M; Hayes Y; Fitzmaurice B; McGing P; Carney DN
Semin Oncol; 1992 Feb; 19(1 Suppl 2):102-6. PubMed ID: 1411620
[TBL] [Abstract][Full Text] [Related]
9. Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.
Nichols CR; Tricot G; Williams SD; van Besien K; Loehrer PJ; Roth BJ; Akard L; Hoffman R; Goulet R; Wolff SN
J Clin Oncol; 1989 Jul; 7(7):932-9. PubMed ID: 2544687
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the renal function in patients with ovarian carcinoma subjected to polychemotherapy including cisplatin or carboplatin].
Gadducci A; Facchini V; Dell'Arciprete T; Del Bravo B; Galigani P; Palla R; Fioretti P
Minerva Ginecol; 1988 Jan; 40(1):33-8. PubMed ID: 3287233
[No Abstract] [Full Text] [Related]
11. Optimal dosing with carboplatin.
Ozols RF
Semin Oncol; 1989 Apr; 16(2 Suppl 5):14-8. PubMed ID: 2655094
[TBL] [Abstract][Full Text] [Related]
12. Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.
Twelves CJ; Ash CM; Miles DW; Thomas DG; Souhami RL
Cancer Chemother Pharmacol; 1991; 27(6):481-3. PubMed ID: 2013119
[TBL] [Abstract][Full Text] [Related]
13. High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.
Lund B; Hansen M; Hansen OP; Hansen HH
J Clin Oncol; 1989 Oct; 7(10):1469-73. PubMed ID: 2674334
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of carboplatin in ovarian cancer].
Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2291-6. PubMed ID: 3044275
[TBL] [Abstract][Full Text] [Related]
15. Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.
Lund B; Hansen M; Hansen OP; Hansen HH
J Clin Oncol; 1990 Jul; 8(7):1226-30. PubMed ID: 2113570
[TBL] [Abstract][Full Text] [Related]
16. A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancer.
Gallagher CJ; Wiltshaw E; Coleman RE; Harper PG
Cancer Chemother Pharmacol; 1989; 24(1):54-7. PubMed ID: 2655961
[TBL] [Abstract][Full Text] [Related]
17. [Phase III study of carboplatin in ovarian cancer].
Kato T; Nishimura H; Yamabe T; Terashima Y; Kasamatsu T; Hirabayashi K; Nishiya I; Yajima A; Takamizawa H; Tsutsui F
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2297-304. PubMed ID: 3044276
[TBL] [Abstract][Full Text] [Related]
18. Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study.
Weiss G; Green S; Alberts DS; Thigpen JT; Hines HE; Hanson K; Pierce HI; Baker LH; Goodwin JW
Eur J Cancer; 1991; 27(2):135-8. PubMed ID: 1827275
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer.
Pfeiffer P; Bennedbaek O; Bertelsen K
Gynecol Oncol; 1990 Mar; 36(3):306-11. PubMed ID: 2180794
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin in the first-line chemotherapy of ovarian cancer.
Alberts DS; Canetta R; Mason-Liddil N
Semin Oncol; 1990 Feb; 17(1 Suppl 2):54-60. PubMed ID: 2406922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
